1st Quarter - Amendment

DUTKO WORLDWIDE, LLC for GENENTECH INC

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 9, 2009 $60,000 Replaced
1st Quarter - Amendment (this page) Apr 13, 2009 $60,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
CECIL SWAMIDOSS New 2008).
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), S. 515 (111th), H.R. 1260 (111th), S. 610 (111th)

Health Issues HCR

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
JUDITH LEMONS —
CECIL SWAMIDOSS New 2008).
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), S. 610 (111th), H.R. 1548 (111th), S. 515 (111th)

Medicare/Medicaid MMM

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
CECIL SWAMIDOSS New 2008).
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), H.R. 1260 (111th), S. 610 (111th), S. 515 (111th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ROCHE HOLDINGS LTD Switzerland Switzerland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.